RESMED INCRMD

時価総額
$357.4億
PER
2012年
6月30日
2013年
6月30日
2014年
6月30日
2015年
6月30日
2016年
6月30日
2017年
6月30日
2018年
6月30日
2019年
6月30日
2020年
6月30日
2021年
6月30日
2022年
6月30日
2023年
6月30日
Net income255307345353352342316405622475779898
Depreciation and amortization8678737387112120151155157160165
Amortization of right-of-use assets----------3432
Stock-based compensation costs (note 10)313843484646485258646571
Income (Loss) from Equity Method Investments, Net of Dividends Received-----------10
(Gain) loss on equity investments (note 5)--------15-1512-10
Restructuring Charges--6-712189-9-9
Gain on insurance recoveries-----------20
Accounts receivable--352827643218-54129-19107
Inventories-19-2716100-3042-1847022312249
Prepaid expenses, net deferred income taxes and other current assets2529-623-1219161485958168138
Accounts payable, accrued expenses and other73303864635201-27-23211-24831
Net cash provided by operating activities383403----505459802737351693
Purchases of property, plant and equipment476473635962636995103135120
Patent registration costs7889999911142114
Business acquisitions, net of cash acquired5354291,042719512839431,013
Purchases of investments (note 5)52111196144732222132
Proceeds from sale of investment (note 5)----------74
Proceeds / (payments) on maturity of foreign currency contracts---2318-315014-1917-15
Net cash used in investing activities-102-78-----102-1,076-180-158-230-1,160
Proceeds from Issuance of Common Stock626933392830233748384749
Taxes paid related to net share settlement of equity awards----------5231
Payments of business combination contingent consideration--101120104-2
Proceeds from Issuance of Long-Term Debt2701505581801,1404503501,5191,190902881,070
Repayment of borrowings1261005601822845451,1467121,284612166405
Dividends paid-97142157168186199212225227245258
Net cash provided by (used in) financing activities-177-154-----1,027581-317-765-128423
Effect of exchange rate changes on cash-----------14-2
Net decrease in cash and cash equivalents--------42316-168-22-46
Income Taxes Paid, Net--90496993171243180221478217
Interest paid------283640242247
Fair value of assets acquired, excluding cash--------151716360
Liabilities assumed--19801-265425132
Goodwill on acquisition-------794202539787
Previously held equity interest----------4-
Deferred payments----------4-33
Fair value of contingent consideration---2132--4--2
Cash paid for acquisitions53-4291,042719512844431,015